FDA Adverse Event Injury Summary report: N

DIAMONDTEMP¿

MDR report key: 23832518 · Received December 17, 2025

Report

Report Number
3015180993-2025-00010
Event Type
Injury
Date Received
December 17, 2025
Date of Event
October 8, 2025
Report Date
December 17, 2025
Manufacturer
EPIX THERAPEUTICS
Product Code
OAE
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING A PULMONARY VEIN ISOLATION ABLATION IT WAS OBSERVED THAT THE CATHETER PERFORATED THE SURFACE OF THE LEFT ATRIUM. A PERICARDIAL EFFUSION OCCURRED, CONFIRMED WITH AN ECHOCARDIOGRAM. A PERICARDIOCENTESIS WAS PERFORMED. THE CASE OUTCOME IS UNKNOWN. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2245975 DIAMONDTEMP¿ CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION OAE EPIX THERAPEUTICS EPIX-UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Life Threatening| R